Impacto das novas tecnologias no tratamento do Diabetes Mellitus
Impact of new technologies in the treatment of Diabetes Mellitus
DOI:
https://doi.org/10.34119/bjhrv5n6-121Keywords:
novas tecnologias, Diabetes, tratamento do DiabetesAbstract
O diabetes mellitus (DM) é uma doença crônica que, quando não controlada, implica diversas complicações agudas e crônicas ao indivíduo, e por isso, o controle da doença deve ser realizado de maneira a evitar hiper/hipoglicemias. Ao longo dos últimos anos, bastantes ferramentas surgiram com a proposta de melhorar a monitorização e a regulação da glicose, facilitando decisões clínicas e melhorando o tratamento. Visto isso, esse trabalho objetivou realizar uma revisão integrativa afim de avaliar o impacto das novas tecnologias na melhora do controle da glicemia e qualidade de vida do paciente com DM. Com esse intuito, foram analisados 14 trabalhos acerca do tema e após observados os resultados, concluiu-se que esses recursos permitem ao paciente menos hipoglicemias e maior controle glicêmico, além de confiança no tratamento e sensação de bem-estar. Desse modo, conhecer sobre essas tecnologias é importante para facilitar a difusão e manejo destas pelos pacientes e profissionais de saúde.
References
A AJJAN, Ramzi; JACKSON, Neil; A THOMSON, Scott. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: a pilot, multicentre, randomised controlled trial. Diabetes And Vascular Disease Research, [S.L.], v. 16, n. 4, p. 385-395, jul. 2019.
AHMADI, Shilan Seyed et al. The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: a randomized clinical trial (gold-4). Diabetes Care, [S.L.], v. 43, n. 9, p. 2017-2024, 8 jul. 2020.
ASHRAFZADEH, Sahar; HAMDY, Osama. Patient-Driven Diabetes Care of the Future in the Technology Era. Cell Metabolism, [S.L.], v. 29, n. 3, p. 564-575, mar. 2019.
BATTELINO, Tadej et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: recommendations from the international consensus on time in range. Diabetes Care, [S.L.], v. 42, n. 8, p. 1593-1603, 8 jun. 2019.
BECK, Roy W et al. Advances in technology for management of type 1 diabetes. The Lancet, [S.L.], v. 394, n. 10205, p. 1265-1273, out. 2019.
BECK, Roy W. et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections. Jama, [S.L.], v. 317, n. 4, p. 371, 24 jan. 2017.
CAPPON, Giacomo et al. Continuous Glucose Monitoring Sensors for Diabetes Management: a review of technologies and applications. Diabetes & Metabolism Journal, [S.L.], v. 43, n. 4, p. 383, 2019.
CHAUGULE, Shraddha; GRAHAM, Claudia. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective. Journal Of Medical Economics, [S.L.], v. 20, n. 11, p. 1128-1135, 11 ago. 2017.
DANNE, Thomas et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care, [S.L.], v. 40, n. 12, p. 1631-1640, 10 nov. 2017.
DICEMBRINI, Ilaria et al. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: a randomized crossover trial. Diabetes, Obesity And Metabolism, [S.L.], v. 22, n. 8, p. 1286-1291, 8 abr. 2020.
DUKE, Danny C et al. Distal technologies and type 1 diabetes management. The Lancet Diabetes & Endocrinology, [S.L.], v. 6, n. 2, p. 143-156, fev. 2018.
GRUNBERGER, George et al. American Association of Clinical Endocrinologists And American College of Endocrinology 2018 Position Statement On Integration of Insulin Pumps And Continuous Glucose Monitoring In Patients With Diabetes Mellitus. Endocrine Practice, [S.L.], v. 24, n. 3, p. 302-308, mar. 2018.
HEINEMANN, Lutz et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. The Lancet, [S.L.], v. 391, n. 10128, p. 1367-1377, abr. 2018.
LI, Adrian; HUSSAIN, Sufyan. Diabetes technologies – what the general physician needs to know. Clinical Medicine, [S.L.], v. 20, n. 5, p. 469-476, set. 2020.
LIND, Marcus et al. Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI. Diabetes Care, [S.L.], v. 44, n. 1, p. 141-149, 16 nov. 2020.
MCAULEY, Sybil A. et al. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: a randomized, controlled trial. Diabetes Care, [S.L.], v. 43, n. 12, p. 3024-3033, 14 out. 2020.
OSKARSSON, Per et al. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the impact randomised controlled trial. Diabetologia, [S.L.], v. 61, n. 3, p. 539-550, 23 dez. 2017.
PILLA, Scott J. et al. Hypoglycemia Communication in Primary Care Visits for Patients with Diabetes. Journal Of General Internal Medicine, [S.L.], v. 36, n. 6, p. 1533-1542, 21 jan. 2021.
SÁ, Juliana Marques et al. Flash glucose monitoring system: impact on glycemic control and body mass index in type 1 diabetes mellitus. Archives Of Endocrinology And Metabolism, [S.L.], v. 65, n. 5, p. 640-647, 30 set. 2021.
SHAH, Nirali A.; LEVY, Carol J.. Emerging technologies for the management of type 2 diabetes mellitus. Journal Of Diabetes, [S.L.], v. 13, n. 9, p. 713-724, 11 maio 2021.
SPEIGHT, Jane et al. Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-year follow-up in the hypocompass randomized clinical trial. Diabetes Technology & Therapeutics, [S.L.], v. 21, n. 11, p. 619-626, 1 nov. 2019.
ŠOUPAL, Jan et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 years of follow-up from the comisair study. Diabetes Care, [S.L.], v. 43, n. 1, p. 37-43, 17 set. 2019.
THABIT, Hood et al. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: the millennials study. Diabetes Care, [S.L.], v. 43, n. 10, p. 2537-2543, 28 jul. 2020.
WAN, Wen et al. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: the diamond randomized trial. Diabetes Care, [S.L.], v. 41, n. 6, p. 1227-1234, 12 abr. 2018.
